$BIEL: FDA Feedback Today......BEST OUTCOME FOR BIEL THAT CAN EVER DREAM OF
Quote:
Upon its review of the submitted information the FDA has provided written feedback and guidance for a 510(k) application to obtain expanded market clearance for treatment of postoperative pain.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.